{"id":31408,"date":"2023-12-15T16:47:01","date_gmt":"2023-12-15T15:47:01","guid":{"rendered":"https:\/\/www.thema-med.com\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/"},"modified":"2023-12-15T16:48:51","modified_gmt":"2023-12-15T15:48:51","slug":"australia-requisiti-piu-chiari-per-la-valutazione-clinica","status":"publish","type":"post","link":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/","title":{"rendered":"AUSTRALIA: Clearer Requirements for Clinical Evaluation"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1144px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:0px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><h2>On November 23, the Therapeutic Good Administration <strong>(TGA)<\/strong> published the revision of the <a href=\"https:\/\/www.tga.gov.au\/sites\/default\/files\/2023-11\/clinical-evidence-guidelines-medical-devices-v3-2.pdf\"><em>Clinical Evidence Guidelines Version 3.2<\/em><\/a>, in which the <strong>clinical evidence requirements<\/strong> for medical devices and IVDs are set out.<\/h2>\n<p>The guideline aims at being a common <strong>point of reference<\/strong> for both industry and the Regulatory Authority, helping Sponsors and Manufacturers to collect, complete and submit clinical evidence to meet Australian requirements, introducing new chapters on <strong>ophthalmic<\/strong> <strong>devices<\/strong> and <strong>medical devices incorporating a medicinal substance<\/strong> and modifications to <strong>breast implants<\/strong> and <strong>tissue expanders<\/strong>. References to <strong>data<\/strong> and <strong>evidence <\/strong>have also been added.<\/p>\n<p>Concerning <strong>ophthalmic devices<\/strong>, the reference section provides guidance on the nature and type of clinical evidence generally expected to demonstrate compliance with the relevant provisions of the Essential Principles.<\/p>\n<p>The section on <strong>substance-based<\/strong> medical devices provides guidance on expectations about devices incorporating, as an integral part, substances that, if used separately, would constitute medicinal products and are likely to act on the patient&#8217;s body with action ancillary to that of the device.<\/p>\n<p>As regards breast implants and tissue expanders, the guideline covers <strong>breast implants<\/strong> filled with saline, silicone gel or alternative fillers intended for breast augmentation or reconstruction and considers <strong>tissue expanders<\/strong> used in breast reconstruction.<\/p>\n<p>The reference section on data and evidence gives summary recommendations, definitions and necessary evidence concerning clinical investigations. Concerning data and evidence, clinical data can be generated either for the device itself or for a comparable device and include data from clinical investigations, literature review, post-market data and other clinical experience data.<\/p>\n<p>The revision of the guideline by the TGA aims at updating the Australian <strong>regulatory framework<\/strong> to keep pace with other world countries such as the USA and China by regulating devices such as substance-based devices that are increasingly used.<\/p>\n<p>&gt;&gt; Through <a href=\"https:\/\/www.thema-med.com\/servizi-consulenza-strategico-regolatoria-aziende-dispositivi-medici-strumenti-medicali-dispositivi-medico-diagnostici-in-vitro\/consulenza-strategico-regolatoria-dispositivi-medici-medical-devices\/\"><strong>strategic-regulatory consulting<\/strong><\/a> Thema supports the<strong>\u00a0<\/strong><a href=\"https:\/\/www.thema-med.com\/servizi-consulenza-strategico-regolatoria-aziende-dispositivi-medici-strumenti-medicali-dispositivi-medico-diagnostici-in-vitro\/local-representative-mercati-esteri\/\"><strong>registration with Therapeutic Good Administration<\/strong><\/a> for the marketing of medical devices and IVDs in Australia.<\/p>\n<p><strong>Source<\/strong><\/p>\n<p><a href=\"https:\/\/www.tga.gov.au\/sites\/default\/files\/2023-11\/clinical-evidence-guidelines-medical-devices-v3-2.pdf\">Clinical Evidence Guidelines Version 3.2<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":115,"featured_media":31405,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-31408","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AUSTRALIA: Clearer Requirements for Clinical Evaluation - Thema Med<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AUSTRALIA: Clearer Requirements for Clinical Evaluation - Thema Med\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/\" \/>\n<meta property=\"og:site_name\" content=\"Thema Med\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-15T15:47:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-15T15:48:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2023\/12\/3-1024x576.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ufficiomarketing\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ufficiomarketing\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/\"},\"author\":{\"name\":\"ufficiomarketing\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/48e37298d13e3cf7f6d907af6a0d796d\"},\"headline\":\"AUSTRALIA: Clearer Requirements for Clinical Evaluation\",\"datePublished\":\"2023-12-15T15:47:01+00:00\",\"dateModified\":\"2023-12-15T15:48:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/\"},\"wordCount\":572,\"publisher\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2023\/12\/3.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/\",\"url\":\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/\",\"name\":\"AUSTRALIA: Clearer Requirements for Clinical Evaluation - Thema Med\",\"isPartOf\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2023\/12\/3.png\",\"datePublished\":\"2023-12-15T15:47:01+00:00\",\"dateModified\":\"2023-12-15T15:48:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#primaryimage\",\"url\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2023\/12\/3.png\",\"contentUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2023\/12\/3.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.thema-med.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AUSTRALIA: Clearer Requirements for Clinical Evaluation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#website\",\"url\":\"https:\/\/www.thema-med.com\/en\/\",\"name\":\"Thema Med\",\"description\":\"Quality and Regulatory Affairs for Medical Devices\",\"publisher\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.thema-med.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Organization\",\"Place\"],\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\",\"name\":\"Thema\",\"alternateName\":\"Thema\",\"url\":\"https:\/\/www.thema-med.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png\",\"contentUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png\",\"width\":2440,\"height\":2851,\"caption\":\"Thema\"},\"image\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/thema-s-r-l-\/\"],\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/48e37298d13e3cf7f6d907af6a0d796d\",\"name\":\"ufficiomarketing\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/61aa792ee358880e0c04a758e6f9078a28e175950ffc09fbeb595cd0ce2f89e2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/61aa792ee358880e0c04a758e6f9078a28e175950ffc09fbeb595cd0ce2f89e2?s=96&d=mm&r=g\",\"caption\":\"ufficiomarketing\"},\"url\":\"https:\/\/www.thema-med.com\/en\/author\/ufficiomarketing\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AUSTRALIA: Clearer Requirements for Clinical Evaluation - Thema Med","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/","og_locale":"en_US","og_type":"article","og_title":"AUSTRALIA: Clearer Requirements for Clinical Evaluation - Thema Med","og_url":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/","og_site_name":"Thema Med","article_published_time":"2023-12-15T15:47:01+00:00","article_modified_time":"2023-12-15T15:48:51+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2023\/12\/3-1024x576.png","type":"image\/png"}],"author":"ufficiomarketing","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ufficiomarketing","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#article","isPartOf":{"@id":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/"},"author":{"name":"ufficiomarketing","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/48e37298d13e3cf7f6d907af6a0d796d"},"headline":"AUSTRALIA: Clearer Requirements for Clinical Evaluation","datePublished":"2023-12-15T15:47:01+00:00","dateModified":"2023-12-15T15:48:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/"},"wordCount":572,"publisher":{"@id":"https:\/\/www.thema-med.com\/en\/#organization"},"image":{"@id":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#primaryimage"},"thumbnailUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2023\/12\/3.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/","url":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/","name":"AUSTRALIA: Clearer Requirements for Clinical Evaluation - Thema Med","isPartOf":{"@id":"https:\/\/www.thema-med.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#primaryimage"},"image":{"@id":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#primaryimage"},"thumbnailUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2023\/12\/3.png","datePublished":"2023-12-15T15:47:01+00:00","dateModified":"2023-12-15T15:48:51+00:00","breadcrumb":{"@id":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#primaryimage","url":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2023\/12\/3.png","contentUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2023\/12\/3.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.thema-med.com\/en\/"},{"@type":"ListItem","position":2,"name":"AUSTRALIA: Clearer Requirements for Clinical Evaluation"}]},{"@type":"WebSite","@id":"https:\/\/www.thema-med.com\/en\/#website","url":"https:\/\/www.thema-med.com\/en\/","name":"Thema Med","description":"Quality and Regulatory Affairs for Medical Devices","publisher":{"@id":"https:\/\/www.thema-med.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thema-med.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Organization","Place"],"@id":"https:\/\/www.thema-med.com\/en\/#organization","name":"Thema","alternateName":"Thema","url":"https:\/\/www.thema-med.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png","contentUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png","width":2440,"height":2851,"caption":"Thema"},"image":{"@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/thema-s-r-l-\/"],"mainEntityOfPage":{"@id":"https:\/\/www.thema-med.com\/en\/2023\/12\/15\/australia-requisiti-piu-chiari-per-la-valutazione-clinica\/"}},{"@type":"Person","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/48e37298d13e3cf7f6d907af6a0d796d","name":"ufficiomarketing","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/61aa792ee358880e0c04a758e6f9078a28e175950ffc09fbeb595cd0ce2f89e2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/61aa792ee358880e0c04a758e6f9078a28e175950ffc09fbeb595cd0ce2f89e2?s=96&d=mm&r=g","caption":"ufficiomarketing"},"url":"https:\/\/www.thema-med.com\/en\/author\/ufficiomarketing\/"}]}},"_links":{"self":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/31408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/users\/115"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/comments?post=31408"}],"version-history":[{"count":1,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/31408\/revisions"}],"predecessor-version":[{"id":31409,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/31408\/revisions\/31409"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/media\/31405"}],"wp:attachment":[{"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/media?parent=31408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/categories?post=31408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/tags?post=31408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}